Cargando…

Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer. TNBC lacks targeted therapy receptors, rendering endocrine and HER2-targeted therapies ineffective. TNBC is typically treated with cytotoxic chemotherapy followed by surgery. Targeting epigeneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salahuddin, Ahmad, Ghanem, Heba, Omran, Gamal A., Helmy, Maged Wasfy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288957/ https://www.ncbi.nlm.nih.gov/pubmed/35843988 http://dx.doi.org/10.1007/s12032-022-01765-1

Ejemplares similares

Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib
por: Salahuddin, Muhammed M., et al.
Publicado: (2021)

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2021)

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017)

Bio-Inspired and Smart Nanoparticles for Triple Negative Breast Cancer Microenvironment
por: Keihan Shokooh, Mahsa, et al.
Publicado: (2021)

CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen
por: Sarkar, S, et al.
Publicado: (2017)

Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ
por: Mishra, Ameet K., et al.
Publicado: (2016)

Epigenetic and transcriptional profiling of triple negative breast cancer
por: Perreault, Andrea A., et al.
Publicado: (2019)

Novel therapeutic strategies in the treatment of triple-negative breast cancer
por: Oualla, Karima, et al.
Publicado: (2017)

Regulation of IMP3 by EGFR Signaling and Repression by ERβ: Implications for Triple Negative Breast Cancer
por: Samanta, Sanjoy, et al.
Publicado: (2012)

PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients
por: Tonetti, Debra A., et al.
Publicado: (2012)

Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research
por: Yan, Shunchao, et al.
Publicado: (2023)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Peterlongo, Paolo, et al.
Publicado: (2021)

Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer’s disease: the role of TNF-α/NF-κB/IL-1β axis inhibition
por: Nafea, Menna, et al.
Publicado: (2022)

A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells
por: Kala, Rishabh, et al.
Publicado: (2016)

Epigenetic Regulation and Dietary Control of Triple Negative Breast Cancer
por: Selmin, Ornella I., et al.
Publicado: (2020)

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2021)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function
por: Bado, Igor, et al.
Publicado: (2016)

ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
por: Song, Wei, et al.
Publicado: (2017)

Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53
por: Scarpetti, Lauren, et al.
Publicado: (2023)

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
por: Temian, Daiana Cosmina, et al.
Publicado: (2018)

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
por: vel Szic, Katarzyna Szarc, et al.
Publicado: (2017)

Epigenetic Dysregulation of KCNK9 Imprinting and Triple-Negative Breast Cancer
por: Skaar, David A., et al.
Publicado: (2021)

Z-ligustilide restores tamoxifen sensitivity of ERα negative breast cancer cells by reversing MTA1/IFI16/HDACs complex mediated epigenetic repression of ERα
por: Ma, Hui, et al.
Publicado: (2017)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020)

Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer
por: Weeks, Shannon E., et al.
Publicado: (2021)

In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer
por: Bouchmaa, Najat, et al.
Publicado: (2023)

Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2014)

Is There an Epigenetic Component Underlying the Resistance of Triple-Negative Breast Cancers to Parp Inhibitors?
por: Lovato, Amanda, et al.
Publicado: (2012)

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
por: Khaled, Noura, et al.
Publicado: (2019)

Epigenetic Alterations in Triple-Negative Breast Cancer—The Critical Role of Extracellular Matrix
por: Zolota, Vasiliki, et al.
Publicado: (2021)

Erratum to epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer
Publicado: (2022)

Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2023)

Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
por: Gao, Tong, et al.
Publicado: (2023)

ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones
por: Tao, Shishi, et al.
Publicado: (2023)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
por: Saifi, Omran, et al.
Publicado: (2022)

Investigation of the protective and therapeutic effects of Lactobacillus casei and Saccharomyces cerevisiae in a breast cancer mouse model
por: Baraka, Kholoud, et al.
Publicado: (2022)

ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells
por: Yuan, Xun, et al.
Publicado: (2017)

Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial
por: Werida, Rehab H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j9nb5sq85ljo0vk94cbqncdvfp